Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Most importantly, cardiovascular monitoring remains warranted despite favorable population-level profiles, as long-standing severe obesity can itself affect cardiac structure and function, and individual-level events are not precluded
This does not mean treatment failed
"You should still improve your health and lifestyle habits, such as improving exercise and your nutrition at the same time as using this drug." Mounjaro and Ozempic are approved to treat Type 2 diabetes, but some doctors prescribe them "off-label" for weight loss
Patients interested in learning more about treatment expectations, side effects, and weight loss results may also review the Semaglutide Weight Loss Guide, Semaglutide Side Effects Guide, and Semaglutide vs Tirzepatide comparison
Retatrutide is a once-weekly subcutaneous investigational medication developed by Eli Lilly for the treatment of obesity and type 2 diabetes
Refunds may be offered on a case-by-case basis
